Cleared Traditional

K201452 - Groshong NXT PICC Catheter

K201452 is the FDA 510(k) clearance for Groshong NXT PICC Catheter by C.R. Bard, Inc.. It is a Class 2 General Hospital device (product code LJS) cleared through the Traditional 510(k) pathway after a 284-day FDA review.

K201452 · C.R. Bard, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2021
Decision
284d
Days
Class 2
Risk

K201452 is an FDA 510(k) clearance for the Groshong NXT PICC Catheter. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on March 12, 2021 after a review of 284 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K201452 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 01, 2020
Decision Date March 12, 2021
Days to Decision 284 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
155d slower than avg
Panel avg: 129d · This submission: 284d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 180
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K201452.
VPS Rhythm DLX Device with TipTracker Technology
K220363 · Arrow International, LLC (A subsidiary of Teleflex, Inc.) · Aug 2022
HydroPICC 5F Dual Lumen Catheter
K213550 · Access Vascular, Inc. · May 2022
BD PowerPiCC Catheter
K210264 · Bard Access Systems, Inc. · Jul 2021
Piccolo Medical SmartPICC System
K200037 · Piccolo Medical, Inc. · Jan 2021
Biowy PICC Catheter S Kit
K192246 · Biowy Corporation · Apr 2020
HydroPICC (PICC-142)
K193015 · Access Vascular, Inc. · Feb 2020